EyePoint Pharmaceuticals, Inc. revenue for the last year amounted to 43.30 M USD, the most of which — 43.27 M USD — came from its highest performing source at the moment, Ophthalmic Products, the year earlier bringing 46.02 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought EyePoint Pharmaceuticals, Inc. 42.05 M USD, and the year before that — 45.27 M USD.